Trustmark National Bank Trust Department’s Edwards Lifesciences EW Stock Holding History

Trustmark National Bank Trust Department’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Hold	17,778	–	–	0.09%	141
2025 Q4	$1.52M	Hold	17,778	–	–	0.1%	138
2025 Q3	$1.38M	Sell	17,778 -33	-0.2%	-$2.58K	0.09%	142
2025 Q2	$1.39M	Buy	17,811 +51	+0.3%	+$3.8K	0.1%	138
2025 Q1	$1.29M	Sell	17,760 -162	-0.9%	-$11.6K	0.1%	137
2024 Q4	$1.33M	Hold	17,922	–	–	0.1%	132
2024 Q3	$1.18M	Hold	17,922	–	–	0.09%	152
2024 Q2	$1.66M	Buy	17,922 +162	+0.9%	+$14.3K	0.13%	123
2024 Q1	$1.7M	Hold	17,760	–	–	0.14%	123
2023 Q4	$1.35M	Hold	17,760	–	–	0.12%	123
2023 Q3	$1.23M	Hold	17,760	–	–	0.12%	120
2023 Q2	$1.68M	Hold	17,760	–	–	0.16%	109
2023 Q1	$1.47M	Hold	17,760	–	–	0.13%	115
2022 Q4	$1.33M	Hold	17,760	–	–	0.12%	120
2022 Q3	$1.47M	Hold	17,760	–	–	0.14%	114
2022 Q2	$1.69M	Hold	17,760	–	–	0.15%	106
2022 Q1	$2.09M	Hold	17,760	–	–	0.17%	102
2021 Q4	$2.3M	Hold	17,760	–	–	0.18%	105
2021 Q3	$2.01M	Hold	17,760	–	–	0.16%	108
2021 Q2	$1.84M	Hold	17,760	–	–	0.15%	112
2021 Q1	$1.49M	Hold	17,760	–	–	0.12%	124
2020 Q4	$1.62M	Hold	17,760	–	–	0.15%	104
2020 Q3	$1.42M	Hold	17,760	–	–	0.14%	104
2020 Q2	$1.23M	Hold	17,760	–	–	0.13%	108
2020 Q1	$1.12M	Hold	17,760	–	–	0.13%	108
2019 Q4	$1.38M	Hold	17,760	–	–	0.13%	110
2019 Q3	$1.3M	Hold	17,760	–	–	0.13%	108
2019 Q2	$1.09M	Hold	17,760	–	–	0.11%	117
2019 Q1	$1.13M	Hold	17,760	–	–	0.12%	111
2018 Q4	$907K	Hold	17,760	–	–	0.1%	115
2018 Q3	$1.03M	Hold	17,760	–	–	0.1%	122
2018 Q2	$862K	Hold	17,760	–	–	0.1%	128
2018 Q1	$826K	Hold	17,760	–	–	0.09%	131
2017 Q4	$667K	Hold	17,760	–	–	0.07%	157
2017 Q3	$647K	Hold	17,760	–	–	0.07%	154
2017 Q2	$700K	Hold	17,760	–	–	0.08%	152
2017 Q1	$557K	Sell	17,760 -22,800	-56%	-$714K	0.07%	164
2016 Q4	$1.27M	Sell	40,560 -6,012	-13%	-$195K	0.17%	114
2016 Q3	$1.87M	Sell	46,572 -168	-0.4%	-$6.33K	0.23%	103
2016 Q2	$1.55M	Sell	46,740 -7,275	-13%	-$249K	0.2%	107
2016 Q1	$1.59M	Buy	54,015 +4,635	+9%	+$128K	0.22%	95
2015 Q4	$1.3M	Buy	49,380 +840	+2%	+$21.8K	0.18%	112
2015 Q3	$1.15M	Buy	48,540 +1,080	+2%	+$26.1K	0.16%	126
2015 Q2	$1.13M	Hold	47,460	–	–	0.15%	129
2015 Q1	$1.13M	Buy	47,460 +29,700	+167%	+$666K	0.15%	134
2014 Q4	$377K	Sell	17,760 -4,404	-20%	-$88.5K	0.05%	232
2014 Q3	$377K	Hold	22,164	–	–	0.05%	254
2014 Q2	$317K	Hold	22,164	–	–	0.04%	286
2014 Q1	$274K	Hold	22,164	–	–	0.03%	301
2013 Q4	$243K	Buy	+22,164	New	+$250K	0.03%	303

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Trustmark National Bank Trust Department's EW Position: Q1 2026 in Review

Trustmark National Bank Trust Department held its Edwards Lifesciences (EW) position steady in Q1 2026 at 17,778 shares worth $1.42M. The position accounts for 0.09% of the portfolio, ranked #141.

Trustmark National Bank Trust Department first reported a position in EW in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.3M in Q4 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Trustmark National Bank Trust Department held 17,778 shares of Edwards Lifesciences worth $1.42M as of Q1 2026.
Trustmark National Bank Trust Department left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.09% of Trustmark National Bank Trust Department's portfolio in Q1 2026, its #141 holding.
Trustmark National Bank Trust Department first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 50 quarters since.
Trustmark National Bank Trust Department's Edwards Lifesciences position peaked at $2.3M in Q4 2021.
1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.